CamPath.com provides resources for for B-cell chronic lymphocytic leukemia

Rating: 0 - 0 votes

Company Logo

Company Name

Company Contact

Website Analysis

• Home Page Analysis
• Web Presence
• Home Page Speed

Domain Whois

WHOIS information for CamPath.com

Powered by who.is

Page Type

This page is about a company.

Title

CamPath® (Alemtuzumab) For Injection - fludarabine refractory B-CLL

Description

Information about Campath®, a treatment for B-cell chronic lymphocytic leukemia (B-CLL) in patients who have been treated with alkylating agents and who have failed fludarabine therapy.

Contact

Genzyme Corporation

Framingham MA

United States 01701

+1.5082702184

Logos

Additional Information

Related Domains

BerLex.com

BerLexOncology.com

Genzymeoncology.com

×

Edit Page Image

×

Select image...

• jpeg, png, or gif
• one megabyte or smaller
• will be resized to 270 pixels wide

Close Save changes

×

Edit Name

×

Name

Close Save changes

×

Edit Contact Information

×

Address

City

State

Country

Postal Code

Phone

Fax

Email

Close Save changes

×

Edit Page Type

×

Page Type
Business / Organization Person Place Thing Other

Close Save changes

×

Map

×

×

Edit Page Rating

×

Your Rating

Close Save changes